Global Pharmaceutical Contract Manufacturing & Contract Research Market is anticipated to reach USD 238.3 billion by 2025. Contract manufacturing offers supports to the complete outsourcing market, due to its widespread adoption and popularity by pharmaceutical establishments. The factors that propel the growth of the Pharmaceutical Contract Manufacturing & Contract Research industry include decrease in the cost of production of APIs, increasing focus on cost reduction, the rising price pressure.
On
the other hand, there are factors that may hamper the growth of the market
including stringent rules and regulations, and steady improvement.
Pharmaceutical Contract Manufacturing & Contract Research Market is
anticipated to grow at a significant CAGR in the upcoming period as the scope,
product types, and its applications are increasing across the globe.
Pharmaceutical
Contract Manufacturing & Contract Research industry may be explored by
type, application, and geography. The market may be explored by product type as
Finished Dosage Formulations (FDF); which may further include
(Parenteral/Injectables, Tablet, Oral Liquids, Capsule, Others), Active
Pharmaceutical Ingredients (API), OTC Medicines and Nutritional Products,
Advanced Drug Delivery Products, and Others. The “Active Pharmaceutical
Ingredients (API)” segment led the Pharmaceutical Contract Manufacturing &
Contract Research Market in 2016 and is anticipated to maintain its dominance
by 2025 due to increasing demand for High Potency Active Pharmaceutical
Ingredients (HPAPI).
Request Sample Copy of This Market Research @
The
key applications that could be explored in the Pharmaceutical Contract
Manufacturing & Contract Research industry include Biopharmaceutical, and
Pharmaceutical. The market by end users could span Non-sterile, and Sterile.
North America accounted for the major share of the Pharmaceutical Contract
Manufacturing & Contract Research Market Size in 2016 and will continue to
lead in the forecast period. However, Asia Pacific is anticipated to raise at a
surplus rate. The factors that could be attributed to the growth include increase
in number of corporations outsourcing the schemes in the emerging economies.
Some
of the key players that fuel the growth of the Pharmaceutical Contract
Manufacturing & Contract Research industry comprise Pharmaceutical Product
Development LLC, Catalent, AbbVie, Patheon, Baxter Biopharma Solutions, Dalton
Pharma Services, Grifols International, S.A., and Lonza AG., and Boehringer
Ingelheim Biopharmaceuticals GmBh. The leading companies are taking up
partnerships, mergers and acquisitions, and joint ventures in order to boost
the inorganic growth of the industry.
Browse Full Research Report @
Market Segment:
Pharmaceutical
Contract Manufacturing/Contract Research Market, Service Types Outlook
(Revenue, USD Billion, 2014 - 2025)
• Manufacturing Services (CMO)
• API/Bulk Drugs
• Advanced Drug Delivery Formulations
Packaging
• Packaging
• Finished Dose Formulations
• Solid Formulations
• Liquid Formulations
• Semi-solid
Formulations
• Research Services (CRO)
• Oncology
• Vaccines
• Inflammation & Immunology
• Cardiology
• Neuroscience
• Others
Pharmaceutical
Contract Manufacturing/Contract Research Market Regional Outlook (Revenue, USD
Billion, 2014 - 2025)
• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• India
• China
• Latin America
• Brazil
• Mexico
• Colombia
• Argentina
• Chile
• Venezuela
• Middle East and Africa (MEA)
• South Africa
Read more insights on @
https://latestmarkettrends.news.blog
Get in touch
At Million Insights, we work with the aim to reach the highest levels
of customer satisfaction. Our representatives strive to understand diverse
client requirements and cater to the same with the most innovative and
functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Comments
Post a Comment